217 related articles for article (PubMed ID: 32321151)
1. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL.
Gao F; Tan Y; Luo H
Braz J Med Biol Res; 2020; 53(5):e9292. PubMed ID: 32321151
[TBL] [Abstract][Full Text] [Related]
2. Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.
Ye S; Guo Q; Tang JP; Yang CD; Shen N; Chen SL
Clin Rheumatol; 2007 Feb; 26(2):186-90. PubMed ID: 16565890
[TBL] [Abstract][Full Text] [Related]
3. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
Front Immunol; 2022; 13():962393. PubMed ID: 35967341
[TBL] [Abstract][Full Text] [Related]
4. The Association of OASL and Type I Interferons in the Pathogenesis and Survival of Intracellular Replicating Bacterial Species.
Leisching G; Wiid I; Baker B
Front Cell Infect Microbiol; 2017; 7():196. PubMed ID: 28580319
[TBL] [Abstract][Full Text] [Related]
5. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1.
Andersen JB; Strandbygård DJ; Hartmann R; Justesen J
Eur J Biochem; 2004 Feb; 271(3):628-36. PubMed ID: 14728690
[TBL] [Abstract][Full Text] [Related]
7. [Interferon-inducible genes 2', 5'-ollgoadenylate synthetase-like and tetratricopeptide repeats 2 are correlated with clinical features of patients with systemic lupus erythematosus].
Zhao ZY; Yang NP; Huang XY; Min L; Liu XX; Zhang J; Ye Y; Shi LJ; Zhong X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):247-51. PubMed ID: 20506645
[TBL] [Abstract][Full Text] [Related]
8. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family.
Kakuta S; Shibata S; Iwakura Y
J Interferon Cytokine Res; 2002 Sep; 22(9):981-93. PubMed ID: 12396720
[TBL] [Abstract][Full Text] [Related]
9. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer.
Zhang Y; Yu C
BMC Cancer; 2020 Jun; 20(1):575. PubMed ID: 32560641
[TBL] [Abstract][Full Text] [Related]
10. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
11. OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.
Huang YZ; Zheng YX; Zhou Y; Xu F; Cui YZ; Chen XY; Wang ZY; Yan BX; Zheng M; Man XY
J Invest Dermatol; 2022 Oct; 142(10):2635-2645.e9. PubMed ID: 35305973
[TBL] [Abstract][Full Text] [Related]
12. OAS1, 2, and 3: Significance During Active Tuberculosis?
Leisching G; Wiid I; Baker B
J Infect Dis; 2018 Apr; 217(10):1517-1521. PubMed ID: 29452387
[TBL] [Abstract][Full Text] [Related]
13. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
Braunstein I; Klein R; Okawa J; Werth VP
Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
[TBL] [Abstract][Full Text] [Related]
14. 2', 5'-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway.
Liao X; Xie H; Li S; Ye H; Li S; Ren K; Li Y; Xu M; Lin W; Duan X; Yang C; Chen L
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276512
[TBL] [Abstract][Full Text] [Related]
15. OASs in Defense of Mycobacterial Infection: Angels or Demons?
Zhang W; Cao X; Cao G; Chen X
Curr Issues Mol Biol; 2021; 40():221-230. PubMed ID: 32609093
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Liu W; Wang Z; Liu L; Yang Z; Liu S; Ma Z; Liu Y; Ma Y; Zhang L; Zhang X; Jiang M; Cao X
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23695-23706. PubMed ID: 32907941
[TBL] [Abstract][Full Text] [Related]
17. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells.
Tanemura S; Seki N; Tsujimoto H; Saito S; Kikuchi J; Sugahara K; Yoshimoto K; Suzuki K; Kaneko Y; Chiba K; Takeuchi T
Int Immunol; 2022 Sep; 34(10):533-544. PubMed ID: 35780437
[TBL] [Abstract][Full Text] [Related]
18. Differential upregulation of human 2'5'OAS genes on systemic sclerosis: Detection of increased basal levels of OASL and OAS2 genes through a qPCR based assay.
de Freitas Almeida GM; Oliveira DB; Botelho LM; Silva LK; Guedes AC; Santos FP; Bonjardim CA; Ferreira PC; Kroon EG
Autoimmunity; 2014 Mar; 47(2):119-26. PubMed ID: 24328427
[TBL] [Abstract][Full Text] [Related]
19. 2'-5'-Oligoadenylate synthetase-like protein inhibits intracellular M. tuberculosis replication and promotes proinflammatory cytokine secretion.
Leisching G; Ali A; Cole V; Baker B
Mol Immunol; 2020 Feb; 118():73-78. PubMed ID: 31855809
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
Liu J; Berthier CC; Kahlenberg JM
Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
